NEW YORK (GenomeWeb News) – Novartis' genomics research arm will collaborate with the Juvenile Diabetes Research Foundation (JDRF) in a drug discovery and development program focused on Type 1 diabetes, JDRF said on Wednesday.

The Genomics Institute of the Novartis Foundation (GNF) will collaborate with JDRF in a four-year program that will be overseen by a review committee made up of GNF and JDRF members and by a scientific advisory board and JDRF volunteers.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

CNN reports that researchers have tied a new variant to opioid addiction risk.

Organoids derived from patients' tumors may help determine what chemotherapy treatment patients would benefit from, according to New Scientist.

An initiative from GenomeAsia 100K hopes to increase the number of South Asians in genetic research, according to NBC News.

In Science this week: genomic analysis of ancient and modern horses indicates population turnover, and more.